1 completed, 1 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow EBI-005: new trials by email Literature Review of EBI-005 trials Research Report on EBI-005
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS) isunakinra - Colorectal Cancer Metastatic | Phase 2 | Recruiting | Buzzard Pharmaceuticals | 20 | 2025-01-30 | 2026-10-23 |
| Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid Tumors Isunakinra, PD-(L)1 Inhibitor - Solid Tumor, Adult | Phase 1 / Phase 2 | Completed | Buzzard Pharmaceuticals | 15 | 2020-09-01 | 2024-08-06 |
Colorectal Neoplasms (1) · Neoplasm Metastasis (1)
United States (2)